Department of Oncology UNIL CHUV, University of Lausanne, 1066 Epalinges, Switzerland.
Lausanne Genomic Technologies Facility (LGTF), University of Lausanne, 1015 Lausanne, Switzerland.
Immunity. 2019 Jan 15;50(1):195-211.e10. doi: 10.1016/j.immuni.2018.12.021. Epub 2019 Jan 8.
Checkpoint blockade mediates a proliferative response of tumor-infiltrating CD8 T lymphocytes (TILs). The origin of this response has remained elusive because chronic activation promotes terminal differentiation or exhaustion of tumor-specific T cells. Here we identified a subset of tumor-reactive TILs bearing hallmarks of exhausted cells and central memory cells, including expression of the checkpoint protein PD-1 and the transcription factor Tcf1. Tcf1PD-1 TILs mediated the proliferative response to immunotherapy, generating both Tcf1PD-1 and differentiated Tcf1PD-1 cells. Ablation of Tcf1PD-1 TILs restricted responses to immunotherapy. Tcf1 was not required for the generation of Tcf1PD-1 TILs but was essential for the stem-like functions of these cells. Human TCF1PD-1 cells were detected among tumor-reactive CD8 T cells in the blood of melanoma patients and among TILs of primary melanomas. Thus, immune checkpoint blockade relies not on reversal of T cell exhaustion programs, but on the proliferation of a stem-like TIL subset.
检查点阻断介导肿瘤浸润 CD8 T 淋巴细胞 (TIL) 的增殖反应。由于慢性激活会促进肿瘤特异性 T 细胞的终末分化或耗竭,因此这种反应的起源一直难以捉摸。在这里,我们鉴定了一组具有衰竭细胞和中央记忆细胞特征的肿瘤反应性 TIL,包括检查点蛋白 PD-1 和转录因子 Tcf1 的表达。Tcf1PD-1 TIL 介导了对免疫治疗的增殖反应,产生了 Tcf1PD-1 和分化的 Tcf1PD-1 细胞。Tcf1PD-1 TIL 的消融限制了对免疫治疗的反应。Tcf1 对于 Tcf1PD-1 TIL 的产生不是必需的,但对于这些细胞的干细胞样功能是必需的。在黑色素瘤患者血液中的肿瘤反应性 CD8 T 细胞和原发性黑色素瘤中的 TIL 中检测到人类 TCF1PD-1 细胞。因此,免疫检查点阻断不是依赖于逆转 T 细胞耗竭程序,而是依赖于类似于干细胞的 TIL 亚群的增殖。